News and Events

1

Meet with us at 2019 AIPLA Annual Meeting

Kirill Osipov, the Head of Legal Department at ARS-Patent, will be attending 2019 AIPLA Annual Meeting on October 24-26 in National Harbor, MD, USA. AIPLA represents a wide and diverse spectrum of individuals from law firms, companies, and institutions involved directly or indirectly in the practice of patent, trademark, copyright, trade secret, and unfair competition […]

Read more

2

Meet ARS-Patent at 4th China Pharma Intellectual Property Summit 2019

Mikhail Khmara, Managing Partner of ARS-Patent and the Head of Patent Department will attend 4th China Pharma IP Summit 2019 (CPIPS 2019) on October 23-25, 2019 at Primus Hotel Shanghai Hongqiao China. CPIPS is the largest IP event focused on pharma and biotech industry and devoted to raise the level in IP management of pharmaceutical […]

Read more

3

Mr. Vladimir Rybakov took part in the FICPI Open Forum in Vienna on October 08 – 12, 2019.

In framework of the Forum he served as a chair on the session “Erroneously filed elements and parts of international applications”. As speakers if this session acted Mr. Charles Pearson, Director Int. Patent Legal Administration USPTO, Mr. Reinould Hesper, Head of dept. Directorate of Legal Affairs, EPO and Mr. Greg Chambers, Patent Attorney, Chair of […]

Read more

4

Meet us at BIO 2019 in Philadelphia

Meet Kirill Osipov, the Head of Legal Department at ARS-Patent, and Pavel Vorobev, patent attorney at ARS-Patent, at the BIO International Convention 2019, June 3-6 in Philadelphia, PA. The Convention is the largest networking event dedicated to biotechnology and pharmaceuticals, which gathers over 16,000 of industry leaders, researchers and service providers working in various life […]

Read more

5

ARS-Patent writes about new domestic regulations intended to fight evergreening of pharmaceutical patents

Anna Pustogvar, patent expert at ARS-Patent, and Kirill Osipov, the Head of Legal Department of ARS-Patent, have been published in spring Newsletters of the AIPLA Chemical Practice Committee. They write about new domestic regulations intended to prevent evergreening of pharmaceutical patents. Read the publication here (the PDF version is provided by AIPLA Chemical Practice Committee)

Read more

6

Meet ARS-Patent at INTA 2019

On May 18-22, 2019, ARS-Patent will attend the annual meeting of International Trademark Association (INTA), which will take place in Boston, Massachusetts. Our firm will be represented by Natalia Belozerova, trademark attorney, and Kseniya Ignatovich, lawyer. The upcoming event will be held for the 141st time. Every year INTA meeting gathers together trademark specialists from […]

Read more

7

More about our presence in IP rankings

Last week IP STARS published results of their extensive annual research on IP firms with the focus on patent practice. ARS-Patent is pleased to remain listed among the leading firms in Russia in patent prosecution category, and is happy to enter a new category – patent contentious, which is a nice recognition of our recent […]

Read more

8

ARS-Patent remains listed in prestigious rankings

ARS-Patent was again listed among the leading IP filers in Russia: Chambers Europe included our firm in the third Band in IP filing category for 2018. Numerous trademark registration cases handled by our firm in the past year were also acknowledged in IP STARS ranking, where ARS-Patent was listed in Tier 2 group in trademark […]

Read more

9

Kirill Osipov’s article has been published in Innovate Magazine of AIPLA

An article by Kirill Osipov, the Head of Legal Department of ARS-Patent, has been recently published in Innovate Magazine of the American Intellectual Property Law Association (AIPLA). The article discusses patenting of pharmaceuticals in Russia. Apart from giving an overview of corresponding legislation, the publication addresses such hot topics as evergreening of pharma patents and […]

Read more

10

Kirill Osipov commented on the recent invalidation of yet another patent of Russian generic producer Nativa

Pharmaceutical Bulletin – one of the largest professional magazines devoted to Russian pharma – published an article on the recent invalidation of yet another patent of Nativa. Nativa is a Russian generic producer, infamous for its involvement in numerous patent infringement cases with the largest originator makers. Nativa’s patent, rendered invalid in the end of […]

Read more

Next page

Latest News

Mr. Vladimir Rybakov took part in the FICPI Open Forum in Vienna on October 08 – 12, 2019.

2019-10-15

In framework of the Forum he served as a chair on the session “Erroneously filed elements and parts of international applications”. As speakers i...

Read more
ARS-Patent writes about new domestic regulations intended to fight evergreening of pharmaceutical patents

2019-05-14

Anna Pustogvar, patent expert at ARS-Patent, and Kirill Osipov, the Head of Legal Department of ARS-Patent, have been published in spring Newsletters ...

Read more

View all our News

MEET WITH US

Meet with us at 2019 AIPLA Annual Meeting

2019-10-18

Kirill Osipov, the Head of Legal Department at ARS-Patent, will be attending 2019 AIPLA Annual Meeting on October 24-26 in National Harbor, MD, USA. ...

Read more
Meet ARS-Patent at 4th China Pharma Intellectual Property Summit 2019

2019-10-18

Mikhail Khmara, Managing Partner of ARS-Patent and the Head of Patent Department will attend 4th China Pharma IP Summit 2019 (CPIPS 2019) on October 2...

Read more

See all Events

Back top